Philip Morris in 2012: Still Smoking

2012 is nearing its end, and now's a good opportunity to look at what happened throughout the year to the stocks you follow. If you know the important things that a company achieved, as well as any challenges it failed to overcome, then you can make a better decision about whether it really deserves a spot in your portfolio.

Today, I'll look at Philip Morris International . Well-known as a spinoff from former parent Altria , Philip Morris represents the international side of what used to be a global tobacco business. With its focus outside the U.S., Philip Morris has avoided many of the controversies involving domestic tobacco companies, but it faces its own challenges. Below, you'll find more on what moved shares of Philip Morris this year.

Stats on Philip Morris

Source: S&P Capital IQ.

What's Philip Morris been up to this year?
Ever since its spinoff, Philip Morris has been a natural pick for investors wanting to avoid the battle in the U.S. against tobacco. This year, the benefits of that strategy became more obvious than ever, as U.S. tobacco companies faced an onslaught from all fronts. Although Reynolds American and Lorillard managed to get an FDA ruling overturned in court that would have forced it to display graphic warning labels, the industry has had to deal with an ad campaign from the Centers for Disease Control as well as increased taxation and regulation at the local level, with New York City among municipalities limiting smoking with its outdoor ban. Altria and Reynolds have had to answer with layoffs to keep margins up.

Even though it doesn't have to deal with U.S. regulators, Philip Morris hasn't been immune from regulatory pressure, as foreign governments start following some of the same tactics that have hurt U.S. tobacco companies. Earlier this year, Australia's highest court upheld a decision that will force Philip Morris, British American Tobacco , and other tobacco companies to remove all brand logos from cigarette packs, leaving only bland packages with warnings that include graphic images. That hits Philip Morris especially hard, as its Marlboro brand is well known around the world.

Perhaps the most interesting thing affecting Philip Morris is the recent rush toward looking at tobacco as a possible source for a flu vaccine. With a huge potential customer base in China, Philip Morris hopes to use vaccine research as a way to break into the emerging market, as state-owned China National Tobacco has a near-monopoly there.

Philip Morris has held up quite well in 2012, with its lucrative dividend helping keep investors happy. The stock faces constant threats, but so far, the company has navigated dangerous minefields quite well.

Don't stop learning
With a decent 2012 for the company nearly over, how will Philip Morris do in 2013? Get our latest views on whether Philip Morris is still a buy from The Motley Fool's premium research report on the company, which includes a more in-depth analysis of its opportunities and challenges ahead. To claim your report, along with a year's worth of analyst updates as key news develops, just click here now.

Click here to add Philip Morris to My Watchlist, which can find all of our Foolish analysis on it and all your other stocks.

The article Philip Morris in 2012: Still Smoking originally appeared on Fool.com.

Fool contributor Dan Caplinger has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.